CA2495252A1 - Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis - Google Patents

Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis Download PDF

Info

Publication number
CA2495252A1
CA2495252A1 CA002495252A CA2495252A CA2495252A1 CA 2495252 A1 CA2495252 A1 CA 2495252A1 CA 002495252 A CA002495252 A CA 002495252A CA 2495252 A CA2495252 A CA 2495252A CA 2495252 A1 CA2495252 A1 CA 2495252A1
Authority
CA
Canada
Prior art keywords
sample
biomarker
expression
osteoarthritis
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002495252A
Other languages
English (en)
French (fr)
Inventor
Wayne K. Marshall
Choong-Chin Liew
Hongwei Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
StageZero Life Sciences Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2495252A1 publication Critical patent/CA2495252A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002495252A 2002-09-12 2003-09-12 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis Abandoned CA2495252A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41018002P 2002-09-12 2002-09-12
US60/410,180 2002-09-12
PCT/US2003/029136 WO2004024892A2 (en) 2002-09-12 2003-09-12 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis

Publications (1)

Publication Number Publication Date
CA2495252A1 true CA2495252A1 (en) 2004-03-25

Family

ID=31994085

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002495252A Abandoned CA2495252A1 (en) 2002-09-12 2003-09-12 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis

Country Status (6)

Country Link
US (2) US7452667B2 (enExample)
EP (1) EP1581652A4 (enExample)
JP (1) JP2006506979A (enExample)
AU (1) AU2003272465A1 (enExample)
CA (1) CA2495252A1 (enExample)
WO (1) WO2004024892A2 (enExample)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10253357B2 (en) 2014-04-24 2019-04-09 Diassess Inc. Colorimetric detection of nucleic acid amplification
USD910200S1 (en) 2018-12-21 2021-02-09 Lucira Health, Inc. Test tube
US11080848B2 (en) 2017-04-06 2021-08-03 Lucira Health, Inc. Image-based disease diagnostics using a mobile device
US11123736B2 (en) 2016-03-14 2021-09-21 Lucira Health, Inc. Systems and methods for performing biological assays
US11125661B2 (en) 2016-03-14 2021-09-21 Lucira Health. Inc. Devices and methods for biological assay sample preparation and delivery
US11291995B2 (en) 2016-03-14 2022-04-05 Lucira Health, Inc. Selectively vented biological assay devices and associated methods
USD962470S1 (en) 2020-06-03 2022-08-30 Lucira Health, Inc. Assay device with LCD display
US11465142B2 (en) 2017-09-14 2022-10-11 Lucira Health, Inc. Multiplexed biological assay device with electronic readout
US12023665B2 (en) 2016-03-14 2024-07-02 Pfizer Inc. Devices and methods for modifying optical properties
US12208389B2 (en) 2017-09-14 2025-01-28 Pfizer Inc. Multiplexed biological assay device with electronic readout

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128270B1 (en) 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
GB0412301D0 (en) 2004-06-02 2004-07-07 Diagenic As Product and method
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
US7662573B2 (en) 2004-08-18 2010-02-16 The United States Of America As Represented By The Department Of Health And Human Services Methods for evaluating osteoarthritis risk
CN103497993A (zh) * 2005-02-07 2014-01-08 基因信息公司 轻度骨关节炎生物标志物及其用途
US8224579B2 (en) * 2005-06-17 2012-07-17 The Brigham And Women's Hospital, Inc. Method of diagnosing osteoarthritis
BRPI0711011A2 (pt) * 2006-05-18 2011-08-23 Molecular Profiling Inst Inc método para a determinação da intervenção médica para um estado de doença, método para a identificação de uma terapia de droga com capacidade de interação com um alvo molecular e sistema para a determinação da intervenção médica individualizada para um estado de doença
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
JP2011117813A (ja) * 2009-12-02 2011-06-16 Hokuriku Univ 変形性関節症のマーカーおよびそれを用いた診断
EP2542701A4 (en) * 2010-03-05 2013-08-21 Univ Missouri BIOMARKER FOR OSTEOARTHRITIS
EP2837373B1 (en) 2010-06-04 2017-04-05 Kao Corporation Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
US20150049177A1 (en) * 2012-02-06 2015-02-19 Biooptico Ab Camera Arrangement and Image Processing Method for Quantifying Tissue Structure and Degeneration
US9034606B2 (en) * 2012-08-23 2015-05-19 New England Biolabs, Inc. Detection of an amplification reaction product using pH-sensitive dyes
USD953561S1 (en) 2020-05-05 2022-05-31 Lucira Health, Inc. Diagnostic device with LED display
KR102466691B1 (ko) * 2020-06-16 2022-11-14 한양대학교 에리카산학협력단 Tsg6 억제제를 포함하는 전이성 고형암 치료용 조성물
CN113249464B (zh) * 2021-04-13 2022-09-27 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 环状rna作为骨关节炎标志物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP0705842A2 (en) * 1994-10-06 1996-04-10 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with 1L-1beta
US20020119452A1 (en) * 2000-01-18 2002-08-29 Phippard Deborah J. Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells
EP1404868A2 (en) * 2001-02-28 2004-04-07 Chondrogene Inc. Compositions and methods relating to osteoarthritis

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10253357B2 (en) 2014-04-24 2019-04-09 Diassess Inc. Colorimetric detection of nucleic acid amplification
US10724079B2 (en) 2014-04-24 2020-07-28 Lucira Health, Inc. Colorimetric detection of nucleic acid amplification
US11584957B2 (en) 2014-04-24 2023-02-21 Lucira Health, Inc. Colorimetric detection of nucleic acid amplification
US11291995B2 (en) 2016-03-14 2022-04-05 Lucira Health, Inc. Selectively vented biological assay devices and associated methods
US11123736B2 (en) 2016-03-14 2021-09-21 Lucira Health, Inc. Systems and methods for performing biological assays
US11125661B2 (en) 2016-03-14 2021-09-21 Lucira Health. Inc. Devices and methods for biological assay sample preparation and delivery
US12023671B2 (en) 2016-03-14 2024-07-02 Pfizer Inc. Selectively vented biological assay devices and associated methods
US12023665B2 (en) 2016-03-14 2024-07-02 Pfizer Inc. Devices and methods for modifying optical properties
US12090482B2 (en) 2016-03-14 2024-09-17 Pfizer Inc. Systems and methods for performing biological assays
US11080848B2 (en) 2017-04-06 2021-08-03 Lucira Health, Inc. Image-based disease diagnostics using a mobile device
US11954851B2 (en) 2017-04-06 2024-04-09 Pfizer Inc. Image-based disease diagnostics using a mobile device
US11465142B2 (en) 2017-09-14 2022-10-11 Lucira Health, Inc. Multiplexed biological assay device with electronic readout
US12208389B2 (en) 2017-09-14 2025-01-28 Pfizer Inc. Multiplexed biological assay device with electronic readout
USD910200S1 (en) 2018-12-21 2021-02-09 Lucira Health, Inc. Test tube
USD962470S1 (en) 2020-06-03 2022-08-30 Lucira Health, Inc. Assay device with LCD display

Also Published As

Publication number Publication date
US20090048115A1 (en) 2009-02-19
JP2006506979A (ja) 2006-03-02
WO2004024892A8 (en) 2005-07-07
US7452667B2 (en) 2008-11-18
AU2003272465A1 (en) 2004-04-30
EP1581652A2 (en) 2005-10-05
WO2004024892A2 (en) 2004-03-25
US20040209275A1 (en) 2004-10-21
EP1581652A4 (en) 2008-02-13

Similar Documents

Publication Publication Date Title
US7452667B2 (en) Diagnosis of mild osteoarthritis by determination of TNFAIP6 and TGFBI RNA levels
US7432049B2 (en) Compositions and methods relating to osteoarthritis
AU2002237124A1 (en) Compositions and methods relating to osteoarthritis
US8483968B2 (en) Method of diagnosing mild osteoarthritis
US20050152908A1 (en) Liver cancer biomarkers
US20130017965A1 (en) Osteoarthritis biomarkers and uses thereof
WO2006055524A2 (en) Biomarkers for diagnosing schizophrenia and bipolar disorder
US7906278B2 (en) Diagnosis of osteoarthritis by determination of asporin RNA levels
CN104450727A (zh) X-连锁低磷酸盐血症性佝偻病的致病基因及其编码蛋白质和应用
AU2008200903A1 (en) Compositions and Methods Relating to Osteoarthritis
US20070054281A1 (en) Compositions and methods relating to osteoarthritis
AU2011239262A1 (en) Osteoarthritis biomarkers and uses thereof
Class et al. Patent application title: METHOD OF DIAGNOSING MILD OSTEOARTHRITIS Inventors: Choong-Chin Liew (Toronto, CA) Hongwei Zhang (Toronto, CA) Hongwei Zhang (Toronto, CA) Adam Dempsey (Toronto, CA) Thomas Yager (Mississauga, CA) Thomas Yager (Mississauga, CA) Samuel Chao (Concord, CA) Samuel Chao (Concord, CA) Assignees: GENENEWS CORPORATION
HK1133888A (en) Mild osteoarthritis biomarkers and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued